Gispert et al. (2016) investigated the levels of YKL-40 in the CSF in 110 subjects, consisting of 49 controls, 27 mild cognitive impairment patients due to AD and 15 AD patients [24]. This evidence concerns the gene CHI3L1 and Cognitive impairment.